Investigational Epcoritamab (DuoBody CD3xCD20) Monotherapy Achieves High Overall and Complete Response Rates in Clinical Trial of Patients With Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) in Preliminary Analysis
Media ReleaseCOPENHAGEN, Denmark; December 8, 2024 Preliminary analyses from the EPCORE® CLL-1…
Mastercard SpendingPulse: US Black Friday Retail Sales Up +3.4% vs. Last Year
Consumers valued deals and promotions on Black Friday, e-commerce sales grew +14.6%…
IDEX Biometrics ASA Preliminary result of the Subsequent Offering
November 30, 2024 12:50 ET | Source: IDEX BIOMETRICS ASA Reference is…
CI Financial Reports Total Assets of $525.3 Billion for October 2024
All financial amounts in Canadian dollars unless stated otherwise.TORONTO--(BUSINESS WIRE)--$CIX #CIFinancial--CI Financial…
3D Systems Announces Preliminary Third Quarter 2024 Revenue Results
November 13, 2024 16:30 ET | Source: 3D Systems Inc. Preliminary third…